Melbourne has placed the winning bid to host the International College of Neuropsychopharmacology (CINP) World Congress on 16-19 June 2025. This will mark the second time the event will take place in the city, underscoring its reputation as a leading global hub for medical research and innovation.
Acknowledged as a pivotal event in its field, CINP’s Annual Congress serves as a platform for the global exchange of knowledge between clinicians and researchers, connecting biologists, researchers, psychiatrists, neurologists, pharmacologists and psychologists from over 50 countries.
CINP2025 which will be held in conjunction with the Annual Meeting of the Asian College of Neuropsychopharmacology, is expected to draw over 1,000 of the world’s leading experts to Melbourne and will enable clinicians to hear about the latest advances in research and novel treatments, and researchers to learn about new clinical needs and challenges.
The bid, spearheaded by Melbourne Convention Bureau (MCB) with support from the Victorian Government and Tourism Australia’s Business Events Bid Fund Program will contribute an estimated $5.9 million to the local economy and provide attendees unparalleled opportunities for communication, collaboration, and networking on an international scale.
Melbourne’s standing as a formidable force in medical research and innovation is enriched by the Victorian Government’s strategic investments in pioneering medical precincts.
Neurosciences, including mental health, is one of the pillars of research excellence in the Melbourne Biomedical Precinct, with strengths across all facets of the drug development and commercialisation pipeline to become one of the world’s top drug discovery centres.
With more than 23,000 professionals engaged in the medical technologies and pharmaceuticals sector, Victoria boasts an impressive annual revenue of over $AU12.7 billion.
This accomplishment is amplified by Victoria’s status as a nurturing environment for medical innovation. Home to a robust network of 22 pharmaceutical manufacturers, supported by 16 major medical research institutes, 11 renowned teaching hospitals, and nine prestigious universities, Victoria’s influence within the healthcare realm is unequivocal.
Such distinction reinforces Melbourne’s position as a coveted destination for global medical and healthcare conferences. The region’s profound impact on the field, coupled with its unparalleled resources and collaborations, demonstrates Melbourne’s reputation as a premiere host city for gatherings that shape the future of medical research, treatments, and advancements.
The congress program, distinguished by its scientific rigor, will feature plenary lectures, pioneering scientific symposia, interactive poster sessions and a dedicated track for early career clinicians and researchers, including opportunities to network with global leaders in the field, as well as both educational and scientific workshops.
(Featured Image: Melbourne’s skyline at dusk – iStock/Kokkai Ng)